Amgen sold $1.3 billion of Repatha last year ... injunction on the launch of its Leqselvi for alopecia areata, a common form of hair loss, in the US.

Two drugs that continuously contribute to Amgen Inc. (NASDAQ:AMGN)’s strong growth are EVENITY, which treats osteoporosis in postmenopausal women, and Repatha ... in the form of dividends ...

The heart-1 study is enrolling patients with an inherited form of very high cholesterol ... The first to reach the market were antibodies – Amgen's Repatha (evolocumab) and Sanofi ...

Amgen's strategic growth through M&A and R&D investments has led to a diversified portfolio. Find out why I give AMGN stock a ...

Thousand Oaks, CA-based Amgen is one of the biggest biotech companies ... Other products are Repatha, Blincyto, Vectibix, Nplate, Kyprolis, Evenity, Otezla, Aimovig, Lumakras/Lumykras, Tezspire ...

Amgen Inc. (NASDAQ:AMGN – Free Report ... XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization ...

Two drugs that continuously contribute to Amgen Inc. (NASDAQ:AMGN)’s strong growth are EVENITY, which treats osteoporosis in postmenopausal women, and Repatha, which treats heart disease and ...

In the latest trading session, Amgen (AMGN) closed at $277.29, marking a -1.89% move from the previous day. This change lagged the S&P 500's 0.13% gain on the day. At the same time, the Dow lost 1 ...

Older drugs such as Repatha for high cholesterol and Evenity, used to treat the bone disease osteoporosis in post-menopausal women, are still among Amgen's best performers. Lastly, the company has ...